+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Epidemic"

Animal Biotechnology - Technologies, Markets and Companies - Product Thumbnail Image

Animal Biotechnology - Technologies, Markets and Companies

  • Report
  • November 2021
  • 365 Pages
  • Global
From
Textbook of Lifestyle Medicine. Edition No. 1 - Product Thumbnail Image

Textbook of Lifestyle Medicine. Edition No. 1

  • Book
  • February 2022
  • 288 Pages
Infectious Disease Surveillance. Edition No. 2 - Product Thumbnail Image

Infectious Disease Surveillance. Edition No. 2

  • Book
  • April 2013
  • 720 Pages
ABC of HIV and AIDS. Edition No. 6. ABC Series - Product Thumbnail Image

ABC of HIV and AIDS. Edition No. 6. ABC Series

  • Book
  • June 2012
  • 144 Pages
Loading Indicator

The Epidemic market within the context of Biotechnology is a sector of the industry that focuses on the development of products and services to address the challenges posed by the spread of infectious diseases. This includes the development of vaccines, diagnostics, treatments, and other preventive measures. It also includes the development of technologies to monitor and track the spread of disease, as well as the development of public health policies and strategies to reduce the impact of epidemics. The Epidemic market is a rapidly growing sector of the biotechnology industry, with many companies investing in research and development to create new products and services. Companies in this market include Gilead Sciences, Moderna, Johnson & Johnson, Novavax, Inovio Pharmaceuticals, and Regeneron Pharmaceuticals. Show Less Read more